UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 265

Sortiert nach

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

The Journal of urology, 2008-07, Vol.180 (1), p.47-54

2008

Link zum Volltext

Verfügbarkeit prüfen

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Drugs & aging, 2012-04, Vol.29 (4), p.259-273

2012

Link zum Volltext

Verfügbarkeit prüfen

Combination Therapy for Overactive Bladder: Who Approves?

European urology, 2018-10, Vol.74 (4), p.510-511

Staskin, David R.

2018

Link zum Volltext

Verfügbarkeit prüfen

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

The American journal of medicine, 2006-03, Vol.119 (3), p.9-15

2006

Link zum Volltext

Verfügbarkeit prüfen

Bladder Pain Syndrome - an Evolution

2nd ed. 2018 edition., 2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence

The Journal of urology, 2019-05, Vol.201 (5), p.967-972

2019

Link zum Volltext

Verfügbarkeit prüfen

Conflict of interest - who benefits?

Neurourology and urodynamics, 2012-11, Vol.31 (8), p.1221-1222

Staskin, David R.

2012

Link zum Volltext

Verfügbarkeit prüfen

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Expert opinion on pharmacotherapy, 2009-12, Vol.10 (18), p.3103-3111

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Urology (Ridgewood, N.J.), 2010-05, Vol.75 (5), p.1144-1148

2010

Link zum Volltext

Verfügbarkeit prüfen

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

Urologic clinics of North America, 2006-11, Vol.33 (4), p.465-473

Staskin, David R.

2006

Link zum Volltext

Verfügbarkeit prüfen

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, p.1

2012

Link zum Volltext

Verfügbarkeit prüfen

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?

The Journal of urology, 2009-12, Vol.182 (6), p.2981-2982

2009

Link zum Volltext

Verfügbarkeit prüfen

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?: B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler J Urol 2009; 181: 2209–2213

The Journal of urology, 2009-12, Vol.182 (6), p.2981-2982

2009

Link zum Volltext

Verfügbarkeit prüfen

Transdermal delivery of drugs for urologic applications: Basic principles and applications

Urology (Ridgewood, N.J.), 2006-04, Vol.67 (4), p.657-664

2006

Link zum Volltext

Verfügbarkeit prüfen

P2-12 EFFICACY AND SAFETY OF VIBEGRON IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: RESULTS FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

The Journal of urology, 2024-05, Vol.211 (5S2)

2024

Link zum Volltext

Verfügbarkeit prüfen

PD54-12 EFFECT OF VIBEGRON ON QUALITY OF LIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Link zum Volltext

Verfügbarkeit prüfen

Stimulating Aspects of Sacral Nerve Stimulation

The Journal of urology, 2006-06, Vol.175 (6), p.1991-1992

Staskin, David R.

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

The American journal of medicine, 2006-03, Vol.119 (3), p.24-28

2006

Link zum Volltext

Verfügbarkeit prüfen

Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. Eur Urol 2008;54:543–62

European urology, 2009-03, Vol.55 (3), p.e49-e50

2009

Link zum Volltext

Verfügbarkeit prüfen

Trospium chloride: a quaternary amine with unique pharmacologic properties

Current urology reports, 2003-12, Vol.4 (6), p.436-440

2003

Link zum Volltext

Verfügbarkeit prüfen

Development of oxybutynin chloride topical gel for overactive bladder

Open access journal of urology, 2011-04, Vol.3, p.35-42

2011

Link zum Volltext

Verfügbarkeit prüfen

Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?

Current medical research and opinion, 2005-06, Vol.21 (6), p.835-837

2005

Link zum Volltext

Verfügbarkeit prüfen

The Q-T interval and antimuscarinic drugs

Current urology reports, 2005-11, Vol.6 (6), p.405-409

2005

Link zum Volltext

Verfügbarkeit prüfen

Management of Incontinence for Family Practice Physicians

The American journal of medicine, 2006-03, Vol.119 (3), p.37-40

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 265

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Englisch
(265)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Urology & Urogenital Medicine
(35)
Humans
(31)
Urology
(29)
Urology & Nephrology
(28)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Urinary Incontinence
(17)
Medicine
(15)
Nephrology. Urinary Tract Diseases
(15)
Overactive Bladder
(14)
Urinary System Involvement In Other Diseases. Miscellaneous
(13)
Urinary Tract. Prostate Gland
(13)
Bladder
(12)
Medicine & Public Health
(12)
Drug Therapy
(9)
Geriatrics/gerontology
(9)
Muscarinic Antagonists - Therapeutic Use
(9)
Interstitial Cystitis
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Combination Therapy for Overactive Bladder: Who Approves?

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

Bladder Pain Syndrome - an Evolution

Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence

Conflict of interest - who benefits?

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?: B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler J Urol 2009; 181: 2209–2213

Transdermal delivery of drugs for urologic applications: Basic principles and applications

P2-12 EFFICACY AND SAFETY OF VIBEGRON IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: RESULTS FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

PD54-12 EFFECT OF VIBEGRON ON QUALITY OF LIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

Stimulating Aspects of Sacral Nerve Stimulation

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. Eur Urol 2008;54:543–62

Trospium chloride: a quaternary amine with unique pharmacologic properties

Development of oxybutynin chloride topical gel for overactive bladder

Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?

The Q-T interval and antimuscarinic drugs

Management of Incontinence for Family Practice Physicians

Aktive Filter

Suchergebnisse filtern